1 ML belimumab 200 MG/ML Prefilled Syringe
- RxCUI
- 1939346
- RxNorm name
- 1 ML belimumab 200 MG/ML Prefilled Syringe
- Display name
- 1 ML belimumab 200 MG/ML Prefilled Syringe
- Full name
- 1 ML belimumab 200 MG/ML Prefilled Syringe
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
Purple Book Biologic Products#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BENLYSTA | BELIMUMAB | GlaxoSmithKline LLC | 2fa3c528-1777-4628-8a55-a69dae2381a3 | 2025-06-20 | Warnings, Adverse reactions | 1939346 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2fa3c528-1777-4628-8a55-a69dae2381a3 | 1 ML belimumab 200 MG/ML Prefilled Syringe | SCD | 37 | These highlights do not include all the information needed to use BENLYSTA safely and effectively. See full prescribing information for BENLYSTA. BENLYSTA (belimumab) for injection, for intravenous use BENLYSTA (belimumab) injection, for subcutaneous use Initial U.S. Approval: 2011 | 20250620 |
| 2fa3c528-1777-4628-8a55-a69dae2381a3 | belimumab 200 MG in 1 ML Prefilled Syringe | PSN | 37 | These highlights do not include all the information needed to use BENLYSTA safely and effectively. See full prescribing information for BENLYSTA. BENLYSTA (belimumab) for injection, for intravenous use BENLYSTA (belimumab) injection, for subcutaneous use Initial U.S. Approval: 2011 | 20250620 |
| 2fa3c528-1777-4628-8a55-a69dae2381a3 | belimumab 200 MG per 1 ML Prefilled Syringe | SY | 37 | These highlights do not include all the information needed to use BENLYSTA safely and effectively. See full prescribing information for BENLYSTA. BENLYSTA (belimumab) for injection, for intravenous use BENLYSTA (belimumab) injection, for subcutaneous use Initial U.S. Approval: 2011 | 20250620 |